Navigation Links
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Date:6/3/2008

file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "Investor Relations -- SEC Filings." There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide the Company's expectations, plans or forecasts of future events and views as of the date of this release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this release.

For More Information, Contact:

James E. Fickenscher/CFO

Auxilium Pharmaceuticals, Inc.

(484) 321-5900

jfickenscher@auxilium.com

William Q. Sargent, Jr. / V.P., IR and Corp. Comm.

Auxilium Pharmaceuticals, Inc.

(484) 321-5926

wsargent@auxilium.com


'/>"/>
SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Alvarado Hospital unveiled its new facility ... & Joint Institute. The institute is entirely devoted ... surgery and joint replacement. The Spine & Joint ... experience-focused approach. For example, patients are encouraged to ... than patient gowns. "From the ...
(Date:7/29/2015)... LAKE FOREST, Calif. , July 29, ... ) ("Cryoport" or the "Company"), the leading ... the life sciences industry, serving markets including ... organizations, vaccine manufacturers, animal health, and reproductive ... completed the sale of common stock and warrants ...
(Date:7/29/2015)...  Ortho-Clinical Diagnostics, Inc. (OCD) today announced the presentation ... address a range of important tests for clinical labs ... The scientific posters will be delivered during the 2015 ... held July 26 - 30 in Atlanta, ... is emerging stronger than ever since becoming a stand-alone ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3
... DIEGO, Feb. 11, 2011 Conatus Pharmaceuticals Inc. today ... Preferred Stock private placement financing.  This financing was led ... and included participation by existing investors; Aberdare Ventures, Advent ... Roche Venture Fund.  Conatus will use the proceeds to ...
... LOS ANGELES, Feb. 11, 2011 Nationally-acclaimed researcher and ... speech at the 11th National Conference on Cancer Nursing ... potentially deadly infections they were supposed to prevent. ... needleless IV connector devices with silver coated or silver ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research 2
(Date:7/29/2015)... ... 30, 2015 , ... Macro Wealth Management (MWM) Presidents have increased ... Lifetime program by encouraging their clients to donate their MWM planning fees to the ... McClellan and Tim Streid, who see charitable giving as an important part of financial ...
(Date:7/29/2015)... City, NY (PRWEB) , ... July 30, 2015 ... ... honors Laura Ballard, M.S., MSTi, as a 2015-2016 inductee into ... this prestigious distinction for leadership in mental health counseling. With more than 700,000 ...
(Date:7/29/2015)... ... ... Avatar Solutions has received official approval from CMS to administer the Consumer ... for PQRS Survey collects information about patients’ experiences of care within the group ... they will receive a 2% penalty in 2017. At this point in time, practices ...
(Date:7/29/2015)... ... 29, 2015 , ... Conventional theories used by economists for the past 150 ... able to unlock mysteries about the behavior of microbial life on earth, according to ... University. , The findings, published July 29 in the open access journal PLOS ONE, ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... a vice president within Abt’s U.S. Health division. In her position, Ramkeesoon ... practices. , Prior to joining Abt, Ramkeesoon spent close to a decade at ...
Breaking Medicine News(10 mins):Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:NAPW Inducts Laura Ballard, Lead Clinician / Founder, Abundant Transformation / Evergreen Professional Counseling, Into its VIP Woman of the Year Circle 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2
... researchers have found that bipolar disorder is more costly ... or coronary artery disease. These findings are based on ... costs (the costs of seeing any specialist and all ... of this review are being presented today at the ...
... -- According to a new Mayo Clinic study, a ... of challenges facing depressed inpatients. Included are an increase ... a higher incidence rate of personality disorder. Additionally, these ... and an increase in psychiatric hospitalizations for psychiatric issues. ...
... 75th Birthday NEW YORK, May 21 Tonight ... be joined by prominent members of the entertainment, ... its co-founder Gloria Steinem,s 75th birthday and the ... to grassroots women activists and philanthropists who ignite ...
... LAUREL, N.J., May 21 The Commission for Case ... Annual Patricia McCollom $1,000 Scholarship. August 1 is the ... be used to help cover the cost of tuition, ... announce the scholarship winner in October, during Case Manager ...
... Meadowlands Helps Raise Awareness & Funds for Cystic FibrosisEAST RUTHERFORD, ... know that on average Cystic Fibrosis affects over 500 individuals ... While progress is being made to better understand what causes ... system, there,s no known cure -- only better treatments that ...
... Angeles, London, New Delhi, Singapore and Washington DC (May 21, ... such as MRI and CT scans, a literature review of ... Diagnostic Medical Sonography (JDMS) describes the use of ... the alternatives. , Since its first uses in the 1950s, ...
Cached Medicine News:Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 2Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 3Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 4Health News:CCMC Accepting Applications for Second Annual Patricia McCollom Scholarship Through Aug. 1 2Health News:State Fair Meadowlands Teams Up & Goes Trucking For Cystic Fibrosis Foundation 2Health News:State Fair Meadowlands Teams Up & Goes Trucking For Cystic Fibrosis Foundation 3
Arm Compression Garment...
Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
Sub Pectoral Bra...
Medicine Products: